QLSF Biotherapeutics
Phase 1/2Discovering next generation antibody-based therapeutics addressing challenging targets for the treatment of cancer.
Founded
2020
Focus
AntibodiesBiologics
About
Discovering next generation antibody-based therapeutics addressing challenging targets for the treatment of cancer.
Funding History
1Total raised: $50M
Series A$50MQLSF ManagementMay 15, 2022
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile